Trial
NCT03520790
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
Stand Up To Cancer; Lustgarten Foundation; American Association for Cancer Research
Condition
Pancreatic Cancer
Intervention
Gemcitabine
Why stopped
Phase II was not pursued due to futility based on the results of the NAPOLI-3 therapeutic clinical trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-21